AMICUS THERAPEUTICS, INC. - COM (FOLD)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
307 M
Holdings value Q1 2024
$3.61 B
Value change Q1 2024
+$16.5 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
240
Number of buys Q1 2024
131
Number of sells Q1 2024
-88
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.002%
CUSIP
03152W109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 307 M $3.61 B +$16.5 M $11.78 240
2023 Q4 304 M $4.31 B +$136 M $14.19 222
2023 Q3 296 M $3.6 B -$89.7 M $12.16 223
2023 Q2 303 M $3.81 B +$92 M $12.56 207
2023 Q1 297 M $3.29 B +$67.1 M $11.09 218
2022 Q4 291 M $3.55 B +$7.37 M $12.21 216
2022 Q3 283 M $2.95 B -$129 M $10.44 211
2022 Q2 286 M $3.07 B +$13.6 M $10.74 195
2022 Q1 270 M $2.55 B -$16.7 M $9.47 196
2021 Q4 298 M $3.44 B +$92.2 M $11.55 211
2021 Q3 292 M $2.79 B +$155 M $9.55 225
2021 Q2 276 M $2.66 B +$5.14 M $9.64 223
2021 Q1 274 M $2.71 B -$251 M $9.88 238
2020 Q4 275 M $6.35 B +$51 M $23.09 264
2020 Q3 277 M $3.91 B -$60.3 M $14.12 232
2020 Q2 281 M $4.24 B +$8.67 M $15.08 212
2020 Q1 280 M $2.58 B +$73.3 M $9.24 182
2019 Q4 272 M $2.65 B +$16.3 M $9.74 203
2019 Q3 270 M $2.17 B +$42.1 M $8.02 190
2019 Q2 268 M $3.35 B +$271 M $12.48 200
2019 Q1 250 M $3.39 B +$287 M $13.60 194
2018 Q4 228 M $2.18 B +$17.6 M $9.58 176
2018 Q3 225 M $2.72 B +$35.8 M $12.09 193
2018 Q2 221 M $3.46 B +$48.7 M $15.62 194
2018 Q1 225 M $3.38 B +$287 M $15.04 197
2017 Q4 206 M $2.96 B +$69.1 M $14.39 182
2017 Q3 198 M $2.99 B +$374 M $15.08 183
2017 Q2 174 M $1.75 B +$127 M $10.07 141
2017 Q1 169 M $1.2 B +$168 M $7.13 134
2016 Q4 156 M $777 M +$23.5 M $4.97 130
2016 Q3 148 M $1.1 B +$113 M $7.40 135
2016 Q2 137 M $748 M -$24.9 M $5.46 126
2016 Q1 139 M $1.17 B +$7.44 M $8.45 130
2015 Q4 139 M $1.35 B +$34.3 M $9.70 137
2015 Q3 127 M $1.75 B +$192 M $13.99 142
2015 Q2 112 M $1.58 B +$450 M $14.15 134
2015 Q1 82 M $890 M +$47.7 M $10.88 124
2014 Q4 79.5 M $662 M +$234 M $8.32 108
2014 Q3 46.8 M $278 M +$45.5 M $5.95 95
2014 Q2 40 M $134 M +$27 M $3.34 59
2014 Q1 34.3 M $71 M -$354 K $2.07 67